Efficacy and Safety of Nonantibiotic Outpatient Treatment in Mild Acute Diverticulitis (DINAMO-study)

医学 急诊科 临床终点 阿莫西林 克拉维酸 抗生素 置信区间 随机对照试验 内科学 门诊部 前瞻性队列研究 外科 生物 微生物学 精神科
作者
Laura Mora-López,Neus Ruiz-Edo,Oscar Estrada-Ferrer,Maria Luisa Piñana-Campón,Meritxell Labró-Ciurans,Jordi Escuder-Perez,Ricard Sales-Mallafré,Pere Rebasa-Cladera,Salvador Navarro‐Soto,Xavier Serra‐Aracil
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:274 (5): e435-e442 被引量:25
标识
DOI:10.1097/sla.0000000000005031
摘要

Mild AD can be treated safely and effectively on an outpatient basis without antibiotics.In recent years, it has shown no benefit of antibiotics in the treatment of uncomplicated AD in hospitalized patients. Also, outpatient treatment of uncomplicated AD has been shown to be safe and effective.A Prospective, multicentre, open-label, noninferiority, randomized controlled trial, in 15 hospitals of patients consulting the emergency department with symptoms compatible with AD.The Participants were patients with mild AD diagnosed by Computed Tomography meeting the inclusion criteria were randomly assigned to control arm (ATB-Group): classical treatment (875/125 mg/8 h amoxicillin/clavulanic acid apart from anti-inflammatory and symptomatic treatment) or experimental arm (Non-ATB-Group): experimental treatment (antiinflammatory and symptomatic treatment). Clinical controls were performed at 2, 7, 30, and 90 days.The primary endpoint was hospital admission. Secondary endpoints included number of emergency department revisits, pain control and emergency surgery in the different arms.Four hundred and eighty patients meeting the inclusion criteria were randomly assigned to Non-ATB-Group (n = 242) or ATB-Group (n = 238). Hospitalization rates were: ATB-Group 14/238 (5.8%) and Non-ATB-Group 8/242 (3.3%) [mean difference 2.58%, 95% confidence interval (CI) 6.32 to -1.17], confirming noninferiority margin. Revisits: ATB-Group 16/238 (6.7%) and Non-ATB-Group 17/242 (7%) (mean difference -0.3, 95% CI 4.22 to -4.83). Poor pain control at 2 days follow up: ATB-Group 13/230 (5.7%), Non-ATB-Group 5/221 (2.3%) (mean difference 3.39, 95% CI 6.96 to -0.18).Nonantibiotic outpatient treatment of mild AD is safe and effective and is not inferior to current standard treatment.ClinicalTrials.gov (NCT02785549); EU Clinical Trials Register (2016-001596-75).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助科研通管家采纳,获得10
3秒前
3秒前
科研通AI5应助科研通管家采纳,获得20
3秒前
6秒前
8秒前
念姬完成签到 ,获得积分10
8秒前
Shuhe_Gong完成签到 ,获得积分10
10秒前
13秒前
熊二发布了新的文献求助10
14秒前
fogsea完成签到,获得积分0
18秒前
包容的忆灵完成签到 ,获得积分10
20秒前
鲲鹏完成签到 ,获得积分10
21秒前
22秒前
xbq完成签到,获得积分10
23秒前
不器完成签到 ,获得积分10
25秒前
生椰拿铁完成签到 ,获得积分10
26秒前
27秒前
31秒前
35秒前
季末默相依完成签到,获得积分10
35秒前
悄悄完成签到 ,获得积分10
35秒前
xbq发布了新的文献求助10
37秒前
bing完成签到 ,获得积分10
37秒前
clock完成签到 ,获得积分10
38秒前
苗条绝义发布了新的文献求助10
40秒前
美好灵寒完成签到 ,获得积分10
44秒前
精明云朵完成签到 ,获得积分10
48秒前
theo完成签到 ,获得积分10
49秒前
小张完成签到 ,获得积分10
50秒前
ANT完成签到 ,获得积分10
52秒前
栗子味的茶完成签到 ,获得积分10
53秒前
唐云炳完成签到 ,获得积分10
54秒前
lyy完成签到 ,获得积分10
55秒前
荔枝完成签到 ,获得积分10
56秒前
轻松的鸿煊完成签到 ,获得积分10
58秒前
点点完成签到 ,获得积分10
1分钟前
马大翔完成签到,获得积分0
1分钟前
ANIVIA完成签到,获得积分10
1分钟前
1分钟前
1分钟前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Mechanistic Modeling of Gas-Liquid Two-Phase Flow in Pipes 2500
Structural Load Modelling and Combination for Performance and Safety Evaluation 800
Conference Record, IAS Annual Meeting 1977 610
Interest Rate Modeling. Volume 3: Products and Risk Management 600
Interest Rate Modeling. Volume 2: Term Structure Models 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3555861
求助须知:如何正确求助?哪些是违规求助? 3131451
关于积分的说明 9391158
捐赠科研通 2831150
什么是DOI,文献DOI怎么找? 1556402
邀请新用户注册赠送积分活动 726516
科研通“疑难数据库(出版商)”最低求助积分说明 715890